top of page

The Future of Aesthetic & Women’s Health Science

Or-Genix is developing hormone-driven pharma-grade topical cosmeceuticals for skin and scalp conditions.

A New Era in Medical Aesthetics

The women’s health and aesthetic industries are undergoing a transformation, driven by demand for safer, more effective treatments.

pexels-ron-lach-8626076.jpg

Unmet Market Need

The women’s health and aesthetic industries are undergoing a transformation, driven by demand for safer, more effective treatments.

pexels-pixabay-220989.jpg

Innovative, Non-Systemic Science

Our bioactives degrade immediately after activation, eliminating systemic absorption concerns.

pexels-artempodrez-6786946.jpg

Patent Protected & Scalable Business Model

Global IP protection ensures exclusivity and long-term commercial viability.

Or-Genix assets represent a major advance in safe and effective skincare for women of all age groups.  We are very excited to be part of the revolution in this skincare paradigm shift
oey09osjuuca4m0mrrbe.webp

Mike Burns

President & COO Ferndale Pharma Group

We now have a novel cosmeceutical agent that can address the signs of estrogen-deficient skin. It’s novel, it’s unique, and its mechanism of action is different from anything we have had in the past.
2024-06-20.png

Diane Berson

M.D.

Or-Genix has created a new category of cosmeceutical products. It raises the bar and recognizes that aging skin needs to be attended to on many levels. Now we have an angle that looks at those hormone receptors without using hormones that have systemic effects.
Untitled_design_77.webp

Charlie McMann

Client Review

Our Hero Scientific Breakthroughs

Hormonal imbalances drive many skin and scalp concerns, yet traditional treatments rely on systemic hormones that carry risks. Or-Genix offers a breakthrough—patented, non-systemic bioactives that deliver targeted benefits without entering the bloodstream.

ORX-440

Topical Anti-Androgen Technology

Blocks androgen receptors to prevent excess oil production and hair growth—treating hormonal acne, hirsutism, and hair thinning. A first-of-its-kind, non-systemic alternative to traditional anti-androgens.

ORX-302

Estrogen Mimic Technology

Targets estrogen receptors to boost collagen, elastin, and skin health addressing facial wrinkles, laxity, pigmentation, and vulvar-vaginal discomfort and atrophy. Degrades after activation for zero systemic absorption.

We are at the forefront of cutting-edge technologies, pushing the boundaries to create effective and groundbreaking solutions for our customers. Our commitment to research and development is what drives us to continually expand our portfolio, refine our technologies, and file new patents that ensure we remain leaders in our field.


We understand that in today’s rapidly evolving market, staying ahead of the curve is essential. That’s why we are always exploring new areas of need and actively seeking out the most effective ingredients that can make a real difference in consumers' lives. By focusing on both current demands and future trends, we aim to deliver products that meet the highest standards of quality, efficacy, and safety.


Our pipeline is built around a simple principle: delivering the most effective ingredients to consumers while driving innovation that transforms industries. Whether through the latest advancements in biotech, sustainable sourcing practices, or breakthrough formulations, we are dedicated to providing solutions that not only meet but exceed expectations.

pexels-ivan-samkov-9628853.jpg
Our Pipeline

At Or-Genix, innovation is 
at the heart of everything we do.

Experts Behind Or-Genix

With decades of expertise spanning biotech, pharmaceuticals, cosmeceuticals, and dermatology, the Or-Genix team is driving a new frontier in medical aesthetics.

pexels-cottonbro-5990042.jpg
bottom of page